参考文献/References:
[1].毛凡,姜莹莹,刘韫宁. 中国居民心脑血管疾病流行现况及危险因素分析：基于2017年中国心血管健康指数研究[J]. 中华预防医学杂志,2021,55(11):1280-1286.
[2].Capes SE,Hunt D,Malmberg K,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes:a systematic overview[J]. Lancet,2000,355(9206):773-778.
[3].Ishihara M,Kagawa E,Inoue I,et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era[J]. Am J Cardiol,2007,99(12):1674-1679.
[4].Mamadjanov T,Volaklis K,Heier M,et al. Admission glucose level and short-term mortality in older patients with acute myocardial infarction:results from the KORA Myocardial Infarction Registry[J]. BMJ Open,2021,11(6):e046641.
[5].Chen G,Li M,Wen X,et al. Association between stress hyperglycemia ratio and in-hospital outcomes in elderly patients with acute myocardial infarction[J]. Front Cardiovasc Med,2021,8:698725.
[6].Demarchi A,Cornara S,Somaschini A,et al. Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? [J]. Nutr Metab Cardiovasc Dis,2021,31(2):528-531.
[7].Paolisso P,Foà A,Bergamaschi L,et al. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction:MINOCA versus MIOCA[J]. Cardiovasc Diabetol,2021,20(1):192.
[8].Sia CH,Chan MH,Zheng H,et al. Optimal glucose,HbA1c,glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients[J]. Cardiovasc Diabetol,2021,20(1):211.
[9].Suleiman M,Hammerman H,Boulos M,et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction:a prospective study[J]. Circulation,2005,111(6):754-760.
[10].Aronson D,Hammerman H,Kapeliovich MR,et al. Fasting glucose in acute myocardial infarction:incremental value for long-term mortality and relationship with left ventricular systolic function[J]. Diabetes Care,2007,30(4):960-966.
[11].Nathan DM,Kuenen J,Borg R,et al. Translating the A1C assay into estimated average glucose values[J]. Diabetes Care,2008,31(8):1473-1478.
[12].Liao WI,Lin CS,Lee CH,et al. An elevated glycemic gap is associated with adverse outcomes in diabetic patients with acute myocardial infarction[J]. Sci Rep,2016,6:27770.
[13].Marenzi G,Cosentino N,Milazzo V,et al. Acute kidney injury in diabetic patients with acute myocardial infarction:role of acute and chronic glycemia[J]. J Am Heart Assoc,2018,7(8):e008122.
[14].Zhu Y,Liu K,Meng S,et al. Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction[J]. Cardiovasc Diabetol,2020,19(1):101.
[15].Roberts GW,Quinn SJ,Valentine N,et al. Relative hyperglycemia,a marker of critical illness:introducing the stress hyperglycemia ratio[J]. J Clin Endocrinol Metab,2015,100(12):4490-4497.
[16].Marenzi G,Cosentino N,Milazzo V,et al. Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction:a prospective study[J]. Diabetes Care,2018,41(4):847-853.
[17].Yang Y,Kim TH,Yoon KH,et al. The stress hyperglycemia ratio,an index of relative hyperglycemia,as a predictor of clinical outcomes after percutaneous coronary intervention[J]. Int J Cardiol,2017,241:57-63.
[18].Yang J,Zheng Y,Li C,et al. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome:insight from a large cohort study in Asia[J]. Diabetes Care,2022,45(4):947-956.
[19].Gao S,Liu Q,Chen H,et al. Predictive value of stress hyperglycemia ratio for the occurrence of acute kidney injury in acute?myocardial infarction patients with diabetes[J]. BMC Cardiovasc Disord,2021,21(1):157.
[20].Thorp AA,Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome[J]. J Diabetes Res,2015,2015:341583.
[21].Barth E,Albuszies G,Baumgart K,et al. Glucose metabolism and catecholamines[J]. Crit Care Med,2007,35(9 suppl):S508-S518.
[22].Deane AM,Horowitz M. Dysglycaemia in the critically ill-significance and management[J]. Diabetes Obes Metab,2013,15(9):792-801.
[23].Ishizuka K,Usui I,Kanatani Y,et al. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes[J]. Endocrinology,2007,148(6):2994-3003.
[24].Kalstad AA,Myhre PL,Laake K,et al. Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial[J]. Circulation,2021,143(6):528-539.
[25].Havmoeller R,Reinier K,Teodorescu C,et al. Elevated plasma free fatty acids are associated with sudden death:a prospective community-based evaluation at the time of cardiac arrest[J]. Heart Rhythm,2014,11(4):691-696.
[26].Gimbrone MA Jr,García-Carde?a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis[J]. Circ Res,2016,118(4):620-636.
[27].Akasaka T,Sueta D,Tabata N,et al. Effects of the mean amplitude of glycemic excursions and vascular endothelial dysfunction on cardiovascular events in nondiabetic patients with coronary artery disease[J]. J Am Heart Assoc,2017,6(5):e004841.
[28].Hussain S,Khan AW,Akhmedov A,et al. Hyperglycemia induces myocardial dysfunction via epigenetic regulation of JunD[J]. Circ Res,2020,127(10):1261-1273.
[29].Cruz-Gonzalez I,Chia S,Raffel OC,et al. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction[J]. Diabetes Res Clin Pract,2010,88(1):97-102.
[30].D’Onofrio N,Sardu C,Paolisso P,et al. MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients[J]. J Cell Physiol,2020,235(2):1438-1452.
[31].Malmberg K,Rydén L,Efendic S,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction(DIGAMI study):effects on mortality at 1 year[J]. J Am Coll Cardiol,1995,26(1):57-65.
[32].Malmberg K,Rydén L,Wedel H,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction(DIGAMI 2):effects on mortality and morbidity[J]. Eur Heart J,2005,26(7):650-661.
[33].Cheung NW,Wong VW,McLean M. The Hyperglycemia:Intensive Insulin Infusion in Infarction (HI-5) study:a randomized controlled trial of insulin infusion therapy for myocardial infarction[J]. Diabetes Care,2006,29(4):765-770.
[34].Collet JP,Thiele H,Barbato E,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J,2021,42(14):1289-1367.
[35].Ibanez B,James S,Agewall S,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J,2018,39(2):119-177.
[36].Del Olmo García MI,Merino-Torres JF. GLP 1 receptor agonists,glycemic variability,oxidative stress and acute coronary syndrome[J]. Med Hypotheses,2020, 136:109504.
[37].Trevisan M,Fu EL,Szummer K,et al. Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction[J]. Eur Heart J Cardiovasc Pharmacother,2021,7(2):104-111.
[38].Lan NSR,Yeap BB,Fegan PG,et al. Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes[J]. Int J Cardiovasc Imaging,2021,37(2):517-527.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(3):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(3):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(3):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(3):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(3):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(3):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(3):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(3):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(3):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[11]任燕霞 金小龙 何胜虎.应激性高血糖比与非糖尿病急性心肌梗死的相关研究[J].心血管病学进展,2020,(7):684.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.003]
REN Yanxia,JIN Xiaolong,HE Shenghu.Stress Hyperglycemia Ratio in Non-diabetic Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(3):684.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.003]